Findings

What do systematic reviews say?

10 questions · 10 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 30%GRADE not reported 1 · 10%Very low 4 · 40%Low 0 · 0%Moderate 1 · 10%High 1 · 10%

Human albumin vs placebo or no treatment

Moderate or severe OHSS · women at high risk of OHSS

It is very uncertain whether human albumin changes moderate or severe OHSS compared with placebo or no treatment (very low certainty).

1 finding from 1 review

Volume expanders for the prevention of ovarian hyperstimulation syndrome 2016 · Cochrane Headline outcomes only
OR 0.67 [0.47, 0.95]
7 studies · 1452 participants
Very low

Human albumin vs placebo or no treatment

Live birth · women at high risk of OHSS

The review found no eligible studies for this question.

1 finding from 1 review

Volume expanders for the prevention of ovarian hyperstimulation syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Human albumin vs placebo or no treatment

Pregnancy rate · women at high risk of OHSS

Human albumin probably leads to lower pregnancy rate compared with placebo or no treatment (moderate certainty).

1 finding from 1 review

Volume expanders for the prevention of ovarian hyperstimulation syndrome 2016 · Cochrane Headline outcomes only
OR 0.72 [0.55, 0.94]
7 studies · 1069 participants
Moderate

Human albumin vs placebo or no treatment

Adverse effects · women at high risk of OHSS

The review found no eligible studies for this question.

1 finding from 1 review

Volume expanders for the prevention of ovarian hyperstimulation syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Human albumin infusion plus furosemide vs glucose

Weight loss rate up to day 10 after treatment · patients of all ages with oedema due to nephrotic syndrome

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Very low

Human albumin infusion plus furosemide vs glucose

Others clinical improvement parameters: Serum sodium · patients of all ages with oedema due to nephrotic syndrome

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Very low

Human albumin infusion plus furosemide vs glucose

Death · patients of all ages with oedema due to nephrotic syndrome

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
12 participants
GRADE not reported

Human albumin infusion plus furosemide vs glucose

Kidney function · patients of all ages with oedema due to nephrotic syndrome

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
2 participants
High

Human albumin infusion plus furosemide vs glucose

Quality of life · patients of all ages with oedema due to nephrotic syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Human albumin infusion plus furosemide vs glucose

Adverse effects: Systolic blood pressure · patients of all ages with oedema due to nephrotic syndrome

1 finding from 1 review

Human albumin infusion for treating oedema in people with nephrotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Very low